Toxicological surveillance of illicit prescription and illegal drug abuse has been carried out using post-mortem data from Clark Country, Nevada, USA, with GC–MS, headspace GC–MS, GC×GC–MS, LC–MS, and ELISA.
Photo Credit: David Orcea/Shutterstock.com
Toxicological surveillance of illicit prescription and illegal drug abuse has been carried out using post-mortem data from Clark Country, Nevada, USA, with gas chromatography–mass spectrometry (GC–MS), headspace GC–MS, GC×GC–MS, liquid chromatography (LC)–MS, and enzyme-linked immunosorbent assays (ELISA) (1).
A modern-day pestilence, substance abuse knows no class, race, or age. Carving through demographics outside of the socially expected and at numbers which most infectious diseases would struggle to compete with-even if allowed to spread unabated. National surveys in the US have revealed a doubling of Americans aged 12 and older from 2004 to 2014, an astounding 6.5 million individuals, who use prescription drugs for conditions other than medical use (2,3). Particularly alarming was the rate of drug use in adolescents with an estimated 655,000 adolescents aged 12–17 abusing prescription drugs-around 2.6% of adolescents within the US (2). Studying the effects of such abuse has proven difficult for researchers to fully quantify, a situation further complicated by the rapid brain and body development associated with these phases in life. Drug use during these periods may result in neurological changes and behavioural consequences that differ from those recorded in adult populations (4).
The majority of research on opioid abuse and associated factors among adolescents has been taken from the National Survey on Drug Use and Health (NSDUH), a self-reported survey conducted annually with approximately 20,000 adolescents aged 12–17. There are positives and negatives to self-reported data, however, and additional information would be a welcome addition in trying to understand overarching trends. As such, researchers investigated 526 referred cases through autopsy on subjects aged 12–17 over an 11-year period 2005 to 2015 in Clark Country, Nevada, USA. Comprehensive toxicological examination of heart blood, subclavian blood, urine, liver tissue, stomach contents, and vitreous fluid was carried out using GC–MS, headspace GC–MS, GC×GC–MS, LC–MS, and ELISA.
The retrospective toxicology found that 47% of individuals had positive drug toxicology at the time of death with illegal drugs being found in 35%, prescription drugs in 19%, and over the counter in 7%. Prevalence rates exceeded those in nationally self-reported data (2). The most commonly used drug was tetrahydrocannabinol (THC), which was found in 29.7% of subjects. Excluding THC, illegal prescription opioids and benzodiazepines were used approximately 1.7 times as much as all other illegal-drugs.
Prescription drugs were found in 1 out of 5 adolescents with 39% being positive for one and 61% being positive for poly-prescription drug use. Of the adolescents positive for prescription drugs, 50% were also positive for illegal drugs.
While the study did have limitations, it offered a brief insight into a severe problem blighting American culture, and with drug trends in youths evolving at a rapid speed, more data are required to fully comprehend the situation and more effectively target prevention initiatives. - L.B.
References
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.